Christopher G. Clement serves as Executive at SAVIENT PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Christopher G. Clement has executed 51 insider transactions totaling $2.9M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 15, 2006 involved receiving (via award) 50,000 shares valued at $0.
Christopher G. Clement currently holds 272,794 shares of SAVIENT PHARMACEUTICALS INC (SVNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher G. Clement has been a net seller of SVNT stock. They have purchased $9.9K and sold $2.8M worth of shares.
Christopher G. Clement's most recent insider trade was on Feb 15, 2006, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted